Souhaitez-vous accéder aux communiqués récents ?
Créez un compte lecteur dès aujourd’hui afin de suivre les secteurs et les entreprises qui vous intéressent, et configurer votre tableau de bord.
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Institutional investors holding positions in Driven Brands Holdings Inc. (NASDAQ: DRVN) during the period between May 9, 2023, and February 24, 2026, may...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP reminds purchasers of Gossamer Bio, Inc. (NASDAQ: GOSS) securities of a pending securities class action. THE CASE: A class...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Institutional investors holding positions in Aquestive Therapeutics, Inc. (NASDAQ: AQST) during the period from June 16, 2025 through January 8, 2026 may...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- On September 17, 2025, monday.com Ltd. (NASDAQ: MNDY) told investors the Company would reach $1.8 billion in revenue by fiscal year 2027. Less than five...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- "Companies that make specific promises to investors about future performance have an obligation to disclose known risks to those projections. The...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP reminds purchasers of Camping World Holdings, Inc. (NYSE: CWH) securities of a pending securities class action. THE CASE: A...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Institutional investors holding positions in Soleno Therapeutics, Inc. (NASDAQ: SLNO) during the period March 26, 2025 through November 4, 2025 may wish...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- "Leading integrated security provider" with "strong year over year growth going forward." That was the promise. A stock that crashed 80% in a single day...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Levi & Korsinsky, LLP announces that a securities class action has been filed against Aldeyra Therapeutics, Inc. (NASDAQ: ALDX). YOU MAY BE AFFECTED...
-
NEW YORK, April 20, 2026 (GLOBE NEWSWIRE) -- Institutional investors holding positions in Nektar Therapeutics (NASDAQ: NKTR) during the period from February 26, 2025 through December 15, 2025 may...